Company intelligence / Profile preview

MedAssessment

Ownership: Private
Development stage: Other

Overview

MedAssessment is a US-based boutique contract research organization (CRO) specializing in pharmacovigilance and drug safety strategy, particularly for early drug development. The company is recognized as an industry leader in medical and drug safety assessments, providing services such as medical assessment, case processing, safety database management (21 CFR Part 11 compliant), and overall pharmacovigilance operations. They are often engaged by small to mid-sized biopharma sponsors to act as the Drug Safety Center of Excellence or to serve as the sponsor’s entire safety department[1][2].

Industry: Contract Research Organization

Partnerships

Partners with pharmaceutical and biotechnology companies with pre-market or early-stage compounds for outsourced pharmacovigilance expertise.

Beyond the preview

Go deeper on MedAssessment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedAssessment.

Explore the full profile